跳到正文
原文
Endpoints News· @endpts · X·· 20 天前AI 评分28
AI 导读

在阿米什和门诺派家庭的支持下,基因疗法初创公司 Plowshare 正在重新思考罕见病治疗的资助与定价方式。https://endpoints.news/backed-by-amish-and-mennonites-a-new-kind-of-gene-therapy-company-takes-shape/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

正文

Backed by Amish and Mennonite families, gene therapy startup Plowshare is rethinking how rare disease treatments get funded and priced. https://endpoints.news/backed-by-amish-and-mennonites-a-new-kind-of-gene-therapy-company-takes-shape/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com